FGFR3 and hepatocellular carcinoma: Different mechanisms may underlie the upregulated FGFR3 in about 50% of HCC cases, e.g. non‐coding FGFR3‐antisense transcripts may increase FGFR3 mRNA stability and expression in tumour cells.26